Southeast Asset Advisors Inc. Buys 430 Shares of Teleflex Incorporated (NYSE:TFX)

Southeast Asset Advisors Inc. increased its stake in shares of Teleflex Incorporated (NYSE:TFX) by 4.1% during the first quarter, according to its most recent filing with the SEC. The fund owned 10,934 shares of the medical technology company’s stock after buying an additional 430 shares during the period. Teleflex accounts for 0.7% of Southeast Asset Advisors Inc.’s investment portfolio, making the stock its 19th largest position. Southeast Asset Advisors Inc.’s holdings in Teleflex were worth $2,118,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of TFX. BlueCrest Capital Management Ltd bought a new position in shares of Teleflex during the first quarter valued at $307,000. State Street Corp boosted its position in shares of Teleflex by 3.2% in the first quarter. State Street Corp now owns 1,374,521 shares of the medical technology company’s stock valued at $266,280,000 after buying an additional 42,014 shares during the period. KCG Holdings Inc. boosted its position in shares of Teleflex by 111.4% in the first quarter. KCG Holdings Inc. now owns 3,742 shares of the medical technology company’s stock valued at $725,000 after buying an additional 1,972 shares during the period. Caisse DE Depot ET Placement DU Quebec acquired a new stake in Teleflex during the first quarter worth approximately $601,000. Finally, Liberty Mutual Group Asset Management Inc. boosted its stake in Teleflex by 3.4% in the first quarter. Liberty Mutual Group Asset Management Inc. now owns 20,252 shares of the medical technology company’s stock worth $3,924,000 after buying an additional 670 shares during the last quarter. Institutional investors and hedge funds own 92.90% of the company’s stock.

Shares of Teleflex Incorporated (TFX) traded up 3.25% during midday trading on Friday, reaching $211.40. The company had a trading volume of 195,674 shares. Teleflex Incorporated has a 12-month low of $136.53 and a 12-month high of $211.75. The firm has a market capitalization of $9.51 billion, a price-to-earnings ratio of 43.88 and a beta of 1.06. The company has a 50 day moving average of $201.21 and a 200 day moving average of $187.08.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, May 4th. The medical technology company reported $1.80 earnings per share for the quarter, beating analysts’ consensus estimates of $1.69 by $0.11. Teleflex had a return on equity of 16.17% and a net margin of 11.75%. The company had revenue of $487.90 million for the quarter, compared to the consensus estimate of $472.81 million. During the same quarter in the prior year, the company earned $1.52 earnings per share. Teleflex’s revenue was up 14.8% on a year-over-year basis. Analysts anticipate that Teleflex Incorporated will post $8.16 EPS for the current year.

The company also recently announced a quarterly dividend, which was paid on Thursday, June 15th. Shareholders of record on Monday, May 15th were issued a $0.34 dividend. This represents a $1.36 dividend on an annualized basis and a yield of 0.64%. The ex-dividend date of this dividend was Thursday, May 11th. Teleflex’s dividend payout ratio is 28.22%.

COPYRIGHT VIOLATION WARNING: This report was originally published by BBNS and is the property of of BBNS. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://baseballnewssource.com/markets/southeast-asset-advisors-inc-increases-position-in-teleflex-incorporated-tfx-updated-updated/1043889.html.

A number of equities research analysts have recently commented on the company. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective on the stock in a research note on Friday, June 23rd. Leerink Swann boosted their price objective on Teleflex from $215.00 to $220.00 and gave the company a “market perform” rating in a research note on Friday, June 9th. Deutsche Bank AG boosted their price objective on Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a research note on Monday, May 8th. Finally, Needham & Company LLC restated a “buy” rating and issued a $224.00 price objective on shares of Teleflex in a research note on Friday, May 5th. Two research analysts have rated the stock with a hold rating and five have assigned a buy rating to the stock. The stock has an average rating of “Buy” and a consensus price target of $217.00.

In other news, VP John Deren sold 2,246 shares of the firm’s stock in a transaction dated Tuesday, May 9th. The stock was sold at an average price of $194.07, for a total value of $435,881.22. Following the transaction, the vice president now owns 3,989 shares of the company’s stock, valued at $774,145.23. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Monday, July 3rd. The stock was sold at an average price of $208.10, for a total value of $41,620.00. Following the completion of the transaction, the director now directly owns 8,080 shares in the company, valued at approximately $1,681,448. The disclosure for this sale can be found here. In the last three months, insiders sold 10,346 shares of company stock worth $2,038,174. 2.39% of the stock is owned by corporate insiders.

Teleflex Company Profile

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Institutional Ownership by Quarter for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with our FREE daily email newsletter.

 


Latest News

Veteran Pitcher Bartolo Colon Considering Retirement
Veteran Pitcher Bartolo Colon Considering Retirement
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Todd Frazier Traded to Yankees for Blake Rutherford and Others
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Tigers Would Include Cash in Verlander Deal and Other MLB Trade Rumors
Todd Frazier Trade to Boston Appears to Be Decided
Todd Frazier Trade to Boston Appears to Be Decided
Chicago White Sox Continue Rebuild Without Jose Quintana
Chicago White Sox Continue Rebuild Without Jose Quintana
Mike Trout Returns from Injury With Single and Stole Base
Mike Trout Returns from Injury With Single and Stole Base


Leave a Reply

 
© 2006-2017 BBNS.